CD4 and Leigh syndrome: As discussed earlier, in the first clinical study with trivalent FSP vaccine in patients with LS-associated or non-LS associated MSI-H CRC, all evaluable vaccinated patients showed FSP-specific humoral and predominantly CD4+ T cell responses (48).